Project Number 5R01AG059008-03 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Assessment of lenalidomide to treat Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator SABBAGH, MARWAN N Principal Investigator First Name MARWAN N Principal Investigator Last Name SABBAGH Awardee Organization CLEVELAND CLINIC LERNER COM-CWRU Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-365: Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01) FY Overall Cost $639,729 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
